Loss-of-function mutations in tumour suppressor genes (APC, SMAD4, SMAD4, and TP53) and/or gain of the GTP-ase activity of Ras protein play a key role in driving CRC development. The gene discussed is SMAD4; the disease is colorectal carcinoma.